Real-Life Outcomes of Ponatinib Treatment in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL): Data from a Nationwide Belgian Registry

被引：3

作者：

Devos, Timothy ^{[1
,2
]}

Havelange, Violaine ^{[3
]}

Theunissen, Koen ^{[4
]}

Meers, Stef ^{[5
]}

Benghiat, Fleur Samantha ^{[6
]}

Gadisseur, Alain ^{[7
]}

Vanstraelen, Gaetan ^{[8
]}

Andre, Marc ^{[9
]}

Bailly, Benjamin ^{[10
]}

Granacher, Nikki ^{[11
]}

Lewalle, Philippe ^{[12
]}

De Becker, Ann ^{[13
]}

Van Eygen, Koen ^{[14
]}

Lejeune, Marie ^{[15
]}

Deeren, Dries ^{[16
]}

Nifosi, Gianfilippo ^{[17
]}

Triffet, Agnes ^{[18
]}

Vrelust, Inge ^{[19
]}

Bekaert, Julie ^{[20
]}

Beck, Michael ^{[21
]}

Selleslag, Dominik ^{[22
]}

机构：

[1] Univ Hosp Leuven, Dept Hematol, Leuven, Belgium

[2] Katholieke Univ Leuven, Dept Microbiol & Immunol, Lab Expt Transplantat, Leuven, Belgium

[3] Clin Univ St Luc, Brussels, Belgium

[4] Jessa Ziekenhuis, Hasselt, Belgium

[5] Algemeen Ziekenhuis Klina, Brasschaat, Belgium

[6] Hop Erasme, Brussels, Belgium

[7] Univ Hosp Antwerp, Edegem, Belgium

[8] Ctr Hosp Pelzer Tourelle, Verviers, Belgium

[9] CHU UCL Namur Site Godinne, Dept Hematol, Yvoir, Belgium

[10] Hop Jolimont, Haine St Paul, Belgium

[11] Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerp, Belgium

[12] Univ Libre Bruxelles, Inst Jules Bordet, Brussels, Belgium

[13] Univ Ziekenhuis Brussel, Jette, Belgium

[14] Algemeen Ziekenhuis Groeninge, Kortrijk, Belgium

[15] Ctr Hosp Univ Liege Sart Tilman, Liege, Belgium

[16] Algemeen Ziekenhuis Delta, Roeselare, Belgium

[17] Ctr Hosp Univ Brugmann, Brussels, Belgium

[18] Ctr Hosp Univ Charleroi Vesale, Charleroi, Belgium

[19] Algemeen Ziekenhuis Sint Elisabeth, Turnhout, Belgium

[20] Incyte Biosci Int Sarl, Lausanne, Switzerland

[21] Incyte Biosci Benelux BV, Amsterdam, Netherlands

[22] Algemeen Ziekenhuis Sint Jan Brugge, Brugge, Belgium

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-127923

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4161

引用

页数：4

共 50 条

[21] Ponatinib for Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph plus ALL) With History of Stem Cell Transplantation (SCT): Efficacy and Safety Results of the PACE Trial
Nicolini, F. E.
DeAngelo, D. J.
Abruzzese, E.
Apperley, J. F.
Holyoake, T. L.
Larson, R. A.
Lustgarten, S.
Rivera, V. M.
Clackson, T.
Conlon, M. G.
Haluska, F. G.
Talpaz, M.
Cortes, J. E.
BONE MARROW TRANSPLANTATION, 2015, 50 : S490 - S490
[22] Blinatumomab plus ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults
Couturier, Marie-Anne
Thomas, Xavier
Raffoux, Emmanuel
Huguet, Francoise
Berthon, Celine
Simand, Celestine
Gallego-Hernanz, Maria-Pilar
Hicheri, Yosr
Berger, Mathilde Hunault
Saillard, Colombe
Leguay, Thibaut
Loiseau, Clemence
Bene, Marie-Christine
Chevallier, Patrice
LEUKEMIA & LYMPHOMA, 2021, 62 (03) : 620 - 629
[23] A phase II trial of ponatinib and blinatumomab in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL)
Short, Nicholas James
Jabbour, Elias
Jain, Nitin
Macaron, Walid
Huang, Xuelin
Montalban-Bravo, Guillermo
Kadia, Tapan M.
Daver, Naval Guastad
Haddad, Fadi
Zoghbi, Marianne
Nasnas, Cedric Christophe
Nasr, Lewis Fady
Mayor, Ejiroghene
Deen, Wuliamatu
Thankachan, Jennifer
Loiselle, Christopher
Garris, Rebecca
Konopleva, Marina
Ravandi, Farhad
Kantarjian, Hagop M.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[24] Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Crisis
Kolenova, Alexandra
Maloney, Kelly W.
Hunger, Stephen P.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (06) : E193 - E195
[25] Treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Ryuzo Ohno
Current Oncology Reports, 2008, 10
[26] Treatment of Adult Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Ohno, Ryuzo
CURRENT ONCOLOGY REPORTS, 2008, 10 (05) : 379 - 387
[27] Is AP24534 (Ponatinib) the next treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia?
Thomas, Xavier
BULLETIN DU CANCER, 2011, 98 (07) : 761 - 767
[28] Impact of Polymorphisms in Pharmacokinetic Genes on Tyrosine Kinase Inhibitor (TKI) Tolerability in Patients with Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph plus ALL)
Patel, Jai N.
Lopes, Karine Eboli
Druhan, Lawrence J.
Zeng, Hang
Beam, Travis
Moore, Donald C.
Salem, Ahmed
Hamadeh, Issam
Savage, Quanisha
Chojecki, Aleksander L.
Ai, Jing
Knight, Thomas G.
Ragon, Brittany Knick
Shah, Nilay A.
Sanikommu, Srinivasa Reddy
Steuerwald, Nury M.
Smith, Mathew
Hamilton, Alicia
Rangavajhula, Keerthana
Bell, Ariel
Drummond, Kendra
Symanowski, James T.
Grunwald, Michael R.
BLOOD, 2022, 140 : 11530 - 11531
[29] Ponatinib Treatment in CML and Ph plus ALL Patients: Real-Life Data from the Czech Registries
Koritakova, Eva
Doubek, Michael
Faber, Edgar
Zackova, Daniela
Horacek, Jan M.
Belohlavkova, Petra
Cmunt, Eduard
Folber, Frantisek
Jindra, Pavel
Klamova, Hana
Koristek, Zdenek
Stejskal, Lukas
Szotkowski, Tomas
Salek, Cyril
Kellnerova, Renata
Chrapava, Marika
BLOOD, 2019, 134
[30] The Importance of Ponatinib (Iclusig®) in the Treatment of Philadelphia-Chhromosome-positive acute lymphoblastic Leukemia (Ph plus ALL)
不详
ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (12)

← 1 2 3 4 5 →